Table_1_The prevalence and clustering of metabolic syndrome risk components in Chinese population: a cross-sectional study.docx by Xu Zhao (133907)

“…</p>Methods<p>68383 participants aged 18-80 years from TIDE were scored on a six-point (0–5) MetS severity score (MSSS), which quantified their cumulative amount of MetS risk components. …”

Table_1_A Baseline for Skeletal Investigations in Medaka (Oryzias latipes): The Effects of Rearing Density on the Postcranial Phenotype.docx by Claudia Di Biagio (12980915)

“…The results from this study reveal that rearing densities greater than 5 medaka/L reduce the animals’ growth. This reduction is related to decreased mineralization of dermal (fin rays) and perichondral (fin supporting elements) bone. …”

Data_Sheet_1_Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease.docx by D. Elizabeth Le (10678956)

“…</p><p>Results: Plasma levels of six quantified oxylipins decreased with the number of diseased arteries; a panel of five oxylipins diagnosed three diseased arteries with 100% sensitivity and 70% specificity. …”

Table_1_Molecular cloning and functional analysis of a plastidial ω3 desaturase from Emiliania huxleyi.DOCX by Kaiwen Sun (1504108)

“…It can produce several polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA, 22:6–4,7,10,13,16,19) and octadecapentaenoic acid (OPA, 18:5–3,6,9,12,15), providing a primary source for nutritionally important ω3 PUFAs in the marine food chain. …”

Table_1_Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis.docx by Peipei Zhou (838409)

“…Compared with the control group, our results showed that SGLT2i could lower levels of LSM [MD = −0.82, 95%CI (−1.38, −0.25), p = 0.005] and CAP [MD = −12.80, 95%CI (−20.57, −5.03), p = 0.001]. …”

Image_1_Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis.jpeg by Peipei Zhou (838409)

“…Compared with the control group, our results showed that SGLT2i could lower levels of LSM [MD = −0.82, 95%CI (−1.38, −0.25), p = 0.005] and CAP [MD = −12.80, 95%CI (−20.57, −5.03), p = 0.001]. …”

Image_1_Molecular cloning and functional analysis of a plastidial ω3 desaturase from Emiliania huxleyi.TIFF by Kaiwen Sun (1504108)

“…It can produce several polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA, 22:6–4,7,10,13,16,19) and octadecapentaenoic acid (OPA, 18:5–3,6,9,12,15), providing a primary source for nutritionally important ω3 PUFAs in the marine food chain. …”

Data_Sheet_1_Overexpression of plastid lipid-associated protein in marine diatom enhances the xanthophyll synthesis and storage.docx by Er-Ying Jiang (15335989)

“…The diameter of the plastoglobules in mutants was decreased by a mean of 19.2% versus the wild-type, while the fucoxanthin level was increased by a mean of 51.2%. …”

Suppression by extracellular QRNA from TNP Ts Sup free of exosomes, or miR-150 alone, associating with B-cell derived Ag-specific exosomes from the assayed CS-effector cell mixture... by Krzysztof Bryniarski (731989)

“…</b></u> Similarly, two day immune B-1 B cell-derived exosomes, supplemented with decreasing doses of miR-150 alone, mediated suppression of TNP-CS-effector cell adoptive transfer (Groups E-G), down to a dose of 750pg per eventual recipient, which is 50 femtomoles per eventual recipient (Group G). …”

Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

RDA analysis of environmental factors and fungal community composition (A), diversity (B). by Xiaoqing Li (186909)

Demographic characteristics of adolescent girls in intervention areas at baseline^a. by Catarina Krug (9199556)

Figure S17 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

Figure S9 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

Aβ causes the downregulation of GKAP. by Francesco Roselli (211670)

“…Aβ42 oligomers decreased the size of GKAP clusters to 47.4%±4.4, 34.9±1.9% and 23.5±2.4% of baseline after 1, 6 and 24 h, respectively; scalebar 5 µm. …”

Figure S2 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

Evaluating different carriers of <i>Metarhizium brunneum</i> F52 microsclerotia for control of adult Asian longhorned beetles (Coleoptera: Cerambycidae) by Tarryn A. Goble (2867552)

“…All three carrier types produced >2–6 × 10⁹ viable conidia/gram at higher water activities (<i>а</i>_w >0.987) but were still capable of producing 2.9 × 10⁷ ± 1.6 × 10⁶ conidia/g (30% glycerol <i>а</i>_w= 0.883) and 1.9 × 10⁷ ± 6.5 × 10⁶ conidia/g (30% PEG200 <i>а</i>_w= 0.924) at the lowest tested water activities. …”

Data_Sheet_1_A Phosphoproteomics Study of the Soybean root necrosis 1 Mutant Revealed Type II Metacaspases Involved in Cell Death Pathway.docx by Feifei Wang (195514)

“…When the p-value was set at ≤0.05 and the fold change of protein accumulation between rn1 and T322 at ≥1.5 or ≤0.67, we detected 118 proteins that showed increased levels and 32 proteins decreased levels in rn1 as compared to that in T322. …”

Presentation_1_Lateral Preoptic Area Neurons Activated by Angiotensin-(1–7) Increase Intravesical Pressure: A Novel Feature in Central Micturition Control.pptx by Gustavo B. Lamy (11111085)

“…The gene and protein expressions of Mas receptors and ACE-2 were also evaluated in the LPA. Angiotensin-(1–7) (5 nmol/μL) or A-779 (Mas receptor antagonist, 50 nmol/μL) was injected into the LPA in anesthetized female Wistar rats; and the IP, mean arterial pressure (MAP), heart rate (HR), and renal conductance (RC) were recorded for 30 min. …”

Biosynthetic pathways of differential and related metabolites in <i>Pseudomonas aeruginosa</i> and their interconnection. by Nawaporn Vinayavekhin (105841)

“…Abbreviations: 2-ABA, 2’-aminobenzoylacetate; 2-HABA, 2’-hydroxylaminobenzoylacetate; 3-oxo-C₁₂-HSL, <i>N</i>-(3-oxododecanoyl)-L-homoserine lactone; ACP, acyl carrier protein; AHQ, 2-alkyl-4-hydroxyquinoline; AQNO, 2-alkyl-4-hydroxyquinoline <i>N</i>-oxide; C₄-HSL, <i>N</i>-butyl-L-homoserine lactone; CoA, coenzyme A; C_n-PQS, 2-alkyl-3-hydroxy-4-quinolone; DRL, dirhamnolipid; HAA, 3-(3-hydroxyalkanoyloxy)alkanoic acid; MRL, monorhamnolipid.…”